[1] 郑云程. GLP-1受体长效激动剂GLP-1-exendin-4/IgG4(Fc)融合蛋白的制备与生物效应[J]. 药学学报, 2015,50(12):1668-1672. [2] 毕华,刘兰,韩春梅,等. Exendin-4的研究进展[J]. 药物分析杂志, 2010,30(12):2441-2445. [3] Kharroubi AT, Darwish HM. Diabetes mellitus:The epidemic of the century[J]. World J Diabetes, 2015, 6(6):850-867. [4] Mao GH, Lu P, Wang YN, et al. Role of PI3K p110β in the differentiation of human embryonic stem cells into islet-like cells[J]. Biochem Biophys Res Commun,2017, 488(1):109-115. [5] 郑春喜,田润华,申黎艳. L-阿拉伯糖防治胰岛素抵抗相关疾病的研究进展[J]. 青岛大学医学院学报, 2016, 52(2):251-252. [6] 周楠,蒋维维,刘娟, 等. HepG2 细胞胰岛素抵抗模型中脂代谢的改变[J]. 南京医科大学学报:自然科学版, 2016, 36(6):705-709. [7] 李秀丽,贺嵩敏,朱莹,等. HepG2细胞胰岛素抵抗模型的建立与鉴定[J]. 中国实验方剂学杂志, 2013, 19(5):203-207. [8] Song G, Yang D, Wang Y, et al. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators[J]. Nature, 2017, 546(7657):312-315. [9] Lee SJ, Diener K, Kaufman S, et al. Limiting glucocorticoid secretion increases the anorexigenic property of Exendin-4[J]. Mol Metab, 2016, 5(7):552-565. [10] 韩江莉. 胰高血糖素样肽-1受体激动剂的心血管作用[J]. 心血管病学进展, 2013, 34(1):56-59. [11] 中华医学会糖尿病学分会. 基于胰高血糖素样肽1降糖药物的临床应用共识[J]. 中华糖尿病杂志, 2014, 6(1):14-20. [12] Lee J, Hong SW, Park SE, et al. Exendin-4 inhibits the expression of SEPP1 and fetuin-A via improvement of palmitic acid-Induced endoplasmic reticulum stress by AMPK[J]. Endocrinol Metabolism, 2015, 30(2):177-184. [13] 杨文英. 人GLP-1类似物利拉鲁肽的最新研究进展[J]. 中华内分泌代谢杂志, 2010, 26(9):841-844. [14] 丁婧,王辉,余诗灏,等. 肥胖大鼠模型的建立及其脂代谢相关分子机制研究[J]. 中国实验动物学报, 2012, 20(5):20-24. [15] 程莉娟,成细华,喻嵘,等. 左归降糖清肝方对小鼠糖尿病合并脂肪肝脂代谢相关基因mRNA表达的影响[J]. 中国老年学杂志,2013,33(17):4182-4184. [16] Hofbauer HF, Schopf FH, Schleifer H, et al.Regulation of gene expression through a transcriptional repressor that senses acyl-chain length in membrane phospholipids[J]. Dev Cell, 2014, 29(6):729-739. [17] Musso G, Gambino R, Cassader M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)[J]. Prog Lipid Res, 2009, 48(1):1-26. [18] 袁美玲,倪红兵. 2型糖尿病载脂蛋白ApoAl、ApoBl00检测的临床研究[J]. 南通医学院学报,2009, 29(6):432-433. [19] Camporez JP, Kanda S, Petersen MC, et al. ApoA5 knockdown improves whole-body insulin sensitivity in high-fat fed mice by reducing ectopic lipid content[J]. J Lipid Res, 2015, 56(3):526-536. [20] 马丽,官滨斌,王林曦,等. Exendin-4可通过下调内质网应激信号标志蛋白表达改善3T3-L1脂肪细胞的胰岛素抵抗[J]. 中国病理生理杂志, 2017, 33(7):1258-1263. [21] 李清明,杨刚毅,李伶,等. Exendin-4改善胰岛素抵抗的作用机制研究[J]. 中国糖尿病杂志, 2008, 16(7):405-408. [22] Cd G, Donnelly D, Wootten D, et al. Glucagon-like peptide-1 and its class b g protein-coupled receptors:A long march to therapeutic successes[J]. Pharmacol Rev, 2016, 68(4):954. |